Alzheimer’s Disease and Related Disorders: Recent Advances in Prevention, Diagnosis and Therapy
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 25 February 2026 | Viewed by 6
Special Issue Editor
Interests: cognition; prodromal; Alzheimer's; Alzheimer; dementia; mild cognitive impairment; mild decline in cognition; disease-modifying; amyloid; tau; neuroinflammation; biomarkers; neuroimaging; PET; PET/CT; PET/MRI
Special Issue Information
Dear Colleagues,
Neurodegenerative disorders leading to cognitive decline are rapidly rising in prevalence in most developed countries, largely because of the increasing median age of their populations. This rise poses potentially major adverse consequences with respect to neurologic and overall health, and caregiver burden. A major thrust of research in this area over the past three decades has been the development and refinement of fluid and neuroimaging biomarkers that can identify these disorders in their earliest stages and guide the implementation of therapies that will be the most effective at the point in time that irreversible neurologic damage is minimal or has not yet occurred. This Special Issue focuses on the latest developments in the biomedical field that promise to contribute to, or have already yielded, significant clinical benefits to people at risk for developing these disorders, or who are already suffering from their debilitating effects.
Prof. Dr. Daniel H. S. Silverman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cognition
- prodromal
- Alzheimer’s
- Alzheimer
- dementia
- mild cognitive impairment
- mild decline in cognition
- disease-modifying
- amyloid
- tau
- neuroinflammation
- biomarkers
- neuroimaging
- PET
- PET/CT
- PET/MRI
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
